Posted: Tue 4th Oct 2022

Volunteers needed in North Wales for vaccine trial to help fight future COVID-19 strains

News and Info from Deeside, Flintshire, North Wales
This article is old - Published: Tuesday, Oct 4th, 2022
Listen to this article
Voiced by Amazon Polly

Researchers are urging people to take part in a new COVID-19 vaccine clinical trial in Wrexham.

The trial is researching the second-generation COVID-19 vaccine designed to deliver protection against serious infection from both current and potential new strains in adults aged 18 to 59.

The study, run by Gritstone Bio, a biotechnology company which develops cancer and infectious disease immunotherapies and vaccines, is being delivered by the North Wales Clinical Research Facility at Wrexham Maelor Hospital.

The trial is looking for volunteers that have already received either the Moderna or Pfizer/BioNTech vaccine with or without authorised boosters, and have no prior history of COVID-19 infection in the last 16 weeks (approximately 4 months).

Dr Orod Osanlou, Principal Investigator for the study and Director of the North Wales Clinical Research Facility said:

“This is an exciting study, which will target many different parts of the SARS-CoV-2 Coronavirus.”

“It targets both the spike protein, which vaccines we currently use target, as well as other parts of the virus.”

“The trial will assess whether this approach can provide better immunity against COVID-19.”

“Volunteers will be screened to receive at least two doses of a COVID-19 vaccine. Screening assessments will include an interview to check your medical history, a physical examination, vital signs, blood samples, and a nasal swab test.”

Once admitted to the trial, volunteers are vaccinated in the clinic and are monitored for 45 minutes to ensure they are feeling healthy before returning home.

After four weeks volunteers will then receive the second COVID-19 vaccine dose.

Volunteers will also have regular medical visits to assess their health and blood samples will be taken to measure immunity to COVID-19.

Dr Nicola Williams, Director of Support and Delivery at Health and Care Research Wales, which oversees all research across Wales, said:

“Over the past few years, Wales has made a significant contribution to COVID-19 research including the vaccine trial programme.”

“Thanks again for everyone who is continuing to dedicate their time by facilitating and participating in this study.”

If you are interested in joining the trial, please contact BCU.Gritstone@wales.nhs.uk to arrange for an appointment, or for more information call 03000 858032.

Spotted something? Got a story? Send a Facebook Message | A direct message on Twitter | Email: News@Deeside.com


Latest News

  • Inside Airbus Broughton’s giant A380 wing plant now being used to make parts for nuclear power stations
  • RSPCA issues advice on protecting pet birds and poultry during bird flu restrictions
  • Inspirational Flintshire fundraisers honoured for raising awareness and funds for lifesaving heart research




  • LATEST NEWS...

    Inside Airbus Broughton’s giant A380 wing plant now being used to make parts for nuclear power stations

    News

    RSPCA issues advice on protecting pet birds and poultry during bird flu restrictions

    News

    Inspirational Flintshire fundraisers honoured for raising awareness and funds for lifesaving heart research

    News

    Deeside food production company gives students insight into business world

    News

    It’s “bordering on a scandal” big 4 supermarkets are “flatly refusing” to reduce their prices by bigger amounts, says RAC

    News

    Energy bills: how much money does turning down the thermostat actually save?

    News

    Nearly half of UK consumers plan to cut back this Christmas, Which? finds

    News

    Critical care and neonatal units amongst areas exempt from nurses’ strike action

    News

    UK Health Security Agency says parents should be on lookout for Strep A symptoms

    News